Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$9,421,401
+$1,384,929 QoQ
Shares Held
37,440
+1.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#952
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026YHB Investment Advisors, Inc. holds $47,554,904 across 9 Drug Manufacturers - General names. ABBV ranks #3 (19.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
45,813 | $16,589,803 | |
| 2 | LLY |
ELI LILLY & Co
|
9,488 | $11,380,192 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
37,440 | $9,421,401 | |
| 4 | JNJ |
Johnson & Johnson
|
24,249 | $6,158,518 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,398 | $1,079,143 | |
| 6 | PFE |
Pfizer Inc
|
44,361 | $1,068,212 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
5,454 | $689,058 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
10,753 | $619,587 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,421,401 | 37,440 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $8,036,472 | 36,951 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $8,361,134 | 36,593 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $8,312,980 | 35,903 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $6,721,671 | 36,212 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $7,580,852 | 36,182 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $6,519,102 | 36,686 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $6,582,798 | 33,334 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $5,732,198 | 33,420 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $6,300,842 | 34,601 | Shares | Sole | 2024-08-15 | |
| 2023-12-31 | $5,469,511 | 35,294 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $5,619,412 | 37,699 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $5,166,356 | 38,346 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,405,558 | 40,193 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $6,344,162 | 39,256 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $5,240,095 | 39,044 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $5,903,245 | 38,543 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $6,166,988 | 38,042 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $4,780,838 | 35,309 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $3,712,346 | 34,415 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $3,690,086 | 32,760 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $3,402,328 | 31,439 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $2,476,557 | 23,113 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $1,977,519 | 22,577 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $4,511,861 | 45,955 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $3,480,511 | 45,682 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||